H-2 alleles contribute to antigen 85-specific interferon-gamma responses during Mycobacterium tuberculosis infection-Reference-Cited by-同舟云学术

H-2 alleles contribute to antigen 85-specific interferon-gamma responses during Mycobacterium tuberculosis infection

Published:2011 Issue:1 Volume:271 Page:53-61
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Beamer Gillian L.,Cyktor Joshua,Carruthers Bridget,Turner Joanne

Funder

NIH R01

NIH T32

NIH K08

Publisher

Elsevier BV

Subject

Immunology

Reference32 articles.

1. Recent studies in the epidemiology of tuberculosis based on the risk of being infected with the tubercle bacilli;Sutherland;Advances in Tuberculosis Research,1976

2. WHO, Global tuberculosis control – surveillance, planning, financing (2009).

3. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice;Mitsos;Genes and Immunity,2000

4. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens;Bellamy;Microbes and Infection,1999

5. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan;Bellamy;Proceedings of the National Academy of Science,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis;Human Vaccines & Immunotherapeutics;2016-06-20

2. Separable roles forMycobacterium tuberculosisESX-3 effectors in iron acquisition and virulence;Proceedings of the National Academy of Sciences;2016-01-04

3. The QTL within the H2 Complex Involved in the Control of Tuberculosis Infection in Mice Is the Classical Class II H2-Ab1 Gene;PLOS Genetics;2015-11-30

4. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune competent mice;Disease Models & Mechanisms;2015-01-01

5. How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?;Expert Review of Neurotherapeutics;2014-09-22